Collplant's ceo to present at the octane aesthetic tech forum conference, in newport beach, california

Rehovot, israel , jan. 8, 2024 /prnewswire/ -- collplant biotechnologies (nasdaq:  clgn), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, today announced that mr. yehiel tal, the company's ceo, will participate in the octane aesthetic tech forum, being held on january 25-26, 2024 in newport beach, ca.
CLGN Ratings Summary
CLGN Quant Ranking